Quick Dispatch:
Your altimmune glp 1 Altimmune: Why I'm Downgrading To Hold Despite MASH Promise (NASDAQ:ALT) orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your altimmune glp 1 Altimmune: Why I'm Downgrading To Hold Despite MASH Promise (NASDAQ:ALT) ships.
Need Help?
Questions about altimmune glp 1 Altimmune: Why I'm Downgrading To Hold Despite MASH Promise (NASDAQ:ALT), sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for altimmune glp 1 Altimmune: Why I'm Downgrading To Hold Despite MASH Promise (NASDAQ:ALT) in your area.
Altimmune (ALT): Odd drug out
21.20
Altimmune, Inc. Closes $75 Million Registered Direct Offering to Advance Pemvidutide Development for Liver Diseases
20.46
No longer a two-horse race: Obesity drug competition expands
24.68
Altimmune: Is There Still Hope For Pemvidutide? I Believe There Is (Upgrade) (NASDAQ:ALT)
27.78
Vikingtherapeutics
23.83
Altimmune: Why I'm Downgrading To Hold Despite MASH Promise (NASDAQ:ALT)
24.85
We're excited to share positive 48-week topline results from our IMPACT Phase 2b trial evaluating our investigational glucagon/GLP-1 dual receptor agonist in MASH. Read more about this milestone and our unique dual-action
26.74
